Cargando…

Tumor mutation burden derived from small next generation sequencing targeted gene panel as an initial screening method

BACKGROUND: With the increasing use of immune checkpoint inhibitors, tumor mutation burden (TMB) assessment is now routinely included in reports generated from targeted sequencing with large gene panels; however, not all patients require comprehensive profiling with large panels. Our study aims to e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Yuan, Li, Yuli, Wang, Weiya, Lizaso, Analyn, Hou, Ting, Jiang, Lili, Huang, Meijuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7082297/ https://www.ncbi.nlm.nih.gov/pubmed/32206555 http://dx.doi.org/10.21037/tlcr.2019.12.27

Ejemplares similares

Novel AMBRA1-ALK fusion identified by next-generation sequencing in advanced gallbladder cancer responds to crizotinib: a case report
por: Zhou, Yuling, et al.
Publicado: (2020)

Comparison of Next-Generation Sequencing and Ventana Immunohistochemistry in Detecting ALK Rearrangements and Predicting the Efficacy of First-Line Crizotinib in Patients with Advanced Non-Small Cell Lung Cancer
por: Zeng, Liang, et al.
Publicado: (2020)

The utility of sputum supernatant as an alternative liquid biopsy specimen for next-generation sequencing-based somatic variation profiling
por: Qin, Ling, et al.
Publicado: (2022)

High-level gain of mesenchymal-epithelial transition factor (MET) copy number using next-generation sequencing as a predictive biomarker for MET inhibitor efficacy
por: Wu, Shibo, et al.
Publicado: (2020)

Targeted sequencing identifies the mutational signature of double primary and metastatic malignancies: a case report
por: Rao, Chuangzhou, et al.
Publicado: (2019)

Exome sequencing covers >98% of mutations identified on targeted next generation sequencing panels
por: LaDuca, Holly, et al.
Publicado: (2017)

Characterization of Frequently Mutated Cancer Genes and Tumor Mutation Burden in Chinese Breast Cancer
por: Xiao, Weikai, et al.
Publicado: (2021)

PB1777: DEVELOPMENT OF NEXT GENERATION SEQUENCING PANELS FOR SCREENING FUSION GENES IN LEUKEMIA
por: Çiğdem, S., et al.
Publicado: (2022)

Mutation Analysis of Nine Chordoma Specimens by Targeted Next-Generation Cancer Panel Sequencing
por: Fischer, Carina, et al.
Publicado: (2015)

Assessment of Blood Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Patients With Non–Small Cell Lung Cancer With Use of a Next-Generation Sequencing Cancer Gene Panel
por: Wang, Zhijie, et al.
Publicado: (2019)

Targeted next-generation sequencing for routine clinical screening of mutations
por: Weaver, Jamie MJ, et al.
Publicado: (2011)

Clinical evaluation of panel testing by next-generation sequencing (NGS) for gene mutations in myeloid neoplasms
por: Au, Chun Hang, et al.
Publicado: (2016)

Mutation profile of non-small cell lung cancer revealed by next generation sequencing
por: Chang, Ya-Sian, et al.
Publicado: (2021)

Incidental findings from cancer next generation sequencing panels
por: Maani, Nika, et al.
Publicado: (2021)

A Targeted Next-Generation Sequencing Panel to Genotype Gliomas
por: Guarnaccia, Maria, et al.
Publicado: (2022)

Implementation of a Targeted Next-Generation Sequencing Panel for Constitutional Newborn Screening in High-Risk Neonates
por: Lee, Hyunjoo, et al.
Publicado: (2019)

Beyond BRAF(V600): clinical mutation panel testing by next-generation sequencing in advanced melanoma
por: Siroy, Alan E., et al.
Publicado: (2014)

Clinical evaluation of integrated panel testing by next-generation sequencing for somatic mutations in neuroblastomas with MYCN unamplification
por: Cao, Yanna, et al.
Publicado: (2017)

Panel‐based next‐generation sequencing identifies novel mutations in Bulgarian patients with inherited retinal dystrophies
por: Kamenarova, Kunka, et al.
Publicado: (2022)

Screening for single nucleotide variants, small indels and exon deletions with a next-generation sequencing based gene panel approach for Usher syndrome
por: Krawitz, Peter M, et al.
Publicado: (2014)

Potential utility of longitudinal somatic mutation and methylation profiling for predicting molecular residual disease in postoperative non‐small cell lung cancer patients
por: Li, Hang, et al.
Publicado: (2021)

Effective response to crizotinib of concurrent KIF5B-MET and MET-CDR2-rearranged non-small cell lung cancer: A case report
por: Liu, Lian-Fang, et al.
Publicado: (2022)

The association between BRAF mutation class and clinical features in BRAF-mutant Chinese non-small cell lung cancer patients
por: Lin, Quan, et al.
Publicado: (2019)

Application of a next-generation sequencing (NGS) panel in newborn screening efficiently identifies inborn disorders of neonates
por: Huang, Xinwen, et al.
Publicado: (2022)

Genetic screening of a Chinese cohort of children with hearing loss using a next-generation sequencing panel
por: Ma, Jing, et al.
Publicado: (2023)

Panel-Based Population Next-Generation Sequencing for Inherited Retinal Degenerations
por: Carrigan, Matthew, et al.
Publicado: (2016)

Development of next generation sequencing panel for UMOD and association with kidney disease
por: Bailie, Caitlin, et al.
Publicado: (2017)

Inter-assay variability of next-generation sequencing-based gene panels
por: Quy, Pham Nguyen, et al.
Publicado: (2022)

Development and Analytical Validation of a Targeted Next-Generation Sequencing Panel to Detect Actionable Mutations for Targeted Therapy
por: Wang, Dandan, et al.
Publicado: (2021)

Use of targeted next generation sequencing to characterize tumor mutational burden and efficacy of immune checkpoint inhibition in small cell lung cancer
por: Ricciuti, Biagio, et al.
Publicado: (2019)

Congenital peribronchial myofibroblastic tumor (CPMT): a case report with long term follow-up and next-generation sequencing (NGS)
por: Zhou, Ping, et al.
Publicado: (2023)

Next-generation sequencing of non-small cell lung cancer using a customized, targeted sequencing panel: Emphasis on small biopsy and cytology
por: DiBardino, David M., et al.
Publicado: (2017)

Early detection of lysosomal diseases by screening of cases of idiopathic splenomegaly and/or thrombocytopenia with a next‐generation sequencing gene panel
por: Muñoz, Gloria, et al.
Publicado: (2019)

Comprehensive Mutation Analysis for Congenital Muscular Dystrophy: A Clinical PCR-Based Enrichment and Next-Generation Sequencing Panel
por: Valencia, C. Alexander, et al.
Publicado: (2013)

Validation and Application of a Custom-Designed Targeted Next-Generation Sequencing Panel for the Diagnostic Mutational Profiling of Solid Tumors
por: Froyen, Guy, et al.
Publicado: (2016)

Detection of a novel panel of 24 genes with high frequencies of mutation in gastric cancer based on next-generation sequencing
por: Zeng, Hui-Hui, et al.
Publicado: (2022)

Implications of mutational spectrum in myelodysplastic syndromes based on targeted next-generation sequencing
por: Xu, Yuanyuan, et al.
Publicado: (2017)

Tumor Mutation Burden Prediction Model in Egyptian Breast Cancer patients based on Next Generation Sequencing
por: Nassar, Auhood, et al.
Publicado: (2021)

Clinical applications of next generation sequencing in cancer: from panels, to exomes, to genomes
por: Shen, Tony, et al.
Publicado: (2015)

The ONDRISeq panel: custom-designed next-generation sequencing of genes related to neurodegeneration
por: Farhan, Sali M K, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_r5ed83eq7p4k35lhs0uep8iq77